IMPACT OF CONDITIONING INTENSITY AND GENOMICS ON RELAPSE AFTER ALLOGENEIC TRANSPLANTATION FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME

Laura W. Dillon, Gege Gui, Brent R. Logan, Mingwei Fei, Jack Ghannam, Yuesheng Li, Abel Licon, Edwin P. Alyea, Asad Bashey, Steven M. Devine, Hugo F. Fernandez, Sergio Giralt, Mehdi Hamadani, Alan Howard, Richard T. Maziarz, David L. Porter, Erica D. Warlick, Marcelo C. Pasquini, Bart L. Scott, Mitchell E. Horwitz, H. Joachim Deeg, Christopher S. Hourigan
doi: https://doi.org/10.1101/2020.08.25.20138461

Article Information

doi 
https://doi.org/10.1101/2020.08.25.20138461
History 
  • August 31, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.

Author Information

  1. Laura W. Dillon, Ph.D.1,*,
  2. Gege Gui, Sc.M.1,*,
  3. Brent R. Logan, Ph.D.2,
  4. Mingwei Fei, M.Sc.2,
  5. Jack Ghannam, B.S.1,
  6. Yuesheng Li, Ph.D.1,
  7. Abel Licon, M.S.3,
  8. Edwin P. Alyea, M.D.4,
  9. Asad Bashey, M.D. Ph.D.5,
  10. Steven M. Devine, M.D.6,
  11. Hugo F. Fernandez, M.D.7,
  12. Sergio Giralt, M.D.8,
  13. Mehdi Hamadani, M.D.9,
  14. Alan Howard, Ph.D.6,
  15. Richard T. Maziarz, M.D.10,
  16. David L. Porter, M.D.11,
  17. Erica D. Warlick, M.D.12,
  18. Marcelo C. Pasquini, M.D.2,
  19. Bart L. Scott, M.D.13,
  20. Mitchell E. Horwitz, M.D.14,
  21. H. Joachim Deeg, M.D.13 and
  22. Christopher S. Hourigan, DM DPhil1,*
  1. 1National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
  2. 2Medical College of Wisconsin, Milwaukee, WI
  3. 3ArcherDX, Boulder, CO
  4. 4Dana Farber Cancer Institute, Boston, MA
  5. 5Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA
  6. 6National Marrow Donor Program and Center for International Blood and Marrow Transplant Research, Minneapolis, MN
  7. 7Moffitt Cancer Center and Research Institute, Tampa, FL
  8. 8Memorial Sloan Kettering Cancer Center, New York, NY
  9. 9West Virginia University Medicine, Morgantown, WV
  10. 10Knight Cancer Institute, Oregon Health & Science University, Portland, OR
  11. 11University of Pennsylvania, Philadelphia, PA
  12. 12University of Minnesota, Minneapolis, MN
  13. 13Fred Hutchinson Cancer Research Center, Seattle, WA
  14. 14Duke University, Durham, NC
  1. ↵*Corresponding author Christopher S. Hourigan, DM, DPhil, Laboratory of Myeloid Malignancies, National Heart, Lung, and Blood Institute, National Institutes of Health, Room 10CRC 5-5130, 10 Center Drive, Bethesda, Maryland 20814-1476; email: hourigan{at}nih.gov

  1. ↵* These authors contributed equally

Back to top
Posted August 31, 2020.
Download PDF

Supplementary Material

Data/Code
Email
IMPACT OF CONDITIONING INTENSITY AND GENOMICS ON RELAPSE AFTER ALLOGENEIC TRANSPLANTATION FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME
Laura W. Dillon, Gege Gui, Brent R. Logan, Mingwei Fei, Jack Ghannam, Yuesheng Li, Abel Licon, Edwin P. Alyea, Asad Bashey, Steven M. Devine, Hugo F. Fernandez, Sergio Giralt, Mehdi Hamadani, Alan Howard, Richard T. Maziarz, David L. Porter, Erica D. Warlick, Marcelo C. Pasquini, Bart L. Scott, Mitchell E. Horwitz, H. Joachim Deeg, Christopher S. Hourigan
medRxiv 2020.08.25.20138461; doi: https://doi.org/10.1101/2020.08.25.20138461
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area